InvestorsHub Logo
Followers 1
Posts 305
Boards Moderated 0
Alias Born 03/22/2012

Re: couldbebetter post# 187722

Thursday, 04/18/2019 1:03:30 PM

Thursday, April 18, 2019 1:03:30 PM

Post# of 429507
I disagree. We should get some $$$ with euro partner and then use that to hire more reps. With DTC ads and fda approval, I can see us getting to 2b easily.

4th q, after fda nod, I see us getting to 175 with ease. Then 500m on 2020 4th Q very easily.

My scenario

1. Euro partner brings 500m to 1B and gets 20% of net revenue.

2. If we get nod on the priority review, JT announces additional hire of 600 to have
total of 1k sales rep around June to be trained for Oct post FDA launch.

3. Bombard DTC ads emphasizing 31% 28% 20% reduction.

4. By this time we will have at least 2 cost effective studies which will be very favorable.

5. 4th Q revenue should be 200m

6. Scripts rise big all through 2020.

7. Achieve 400m rev 4th Q of 2020 and voila, we are run rate of 2B.

We will be trading 50 to 70 by then. Easily sold to BP for triple digitz.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News